Pfizer ACAT Inhibitor Phase III Underway; Zocor, Lipitor Prepare For Crestor

Pfizer will receive Phase III data on the anti-atherosclerotic agent avasimibe during 2001, Worldwide Development President Peter Corr told a Pfizer securities analysts meeting Dec. 11 in New York City.